Molecular and Cellular Pharmacology, Vol 6, No 3 (2014)
FDA Approves Opdivo for Advanced Melanoma
FDA News Release
Abstract
The U.S. Food and Drug Administration today granted accelerated approval to Opdivo (nivolumab), a new treatment for patients with unresectable (cannot be removed by surgery) or metastatic (advanced) melanoma who no longer respond to other drugs..….(click PDF to read more)
Full Text: PDF
Our partner: Crossroads Pharmacy 2800 Hwy 101, Rogersville, AL 35652 LumiText Publishing, P.O. Box 774, Ellicott City, MD 21041 Copyright © 2008 LumiText Publishing. All rights reserved.